Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:21 PM
Ignite Modification Date:
2025-12-24 @ 1:21 PM
NCT ID:
NCT01426295
Eligibility Criteria:
Inclusion Criteria:
* Patients \> 18 years
Patient receiving:
* Conditioning of autologous bone marrow transplantation by high dose melphalan (HD) as part of the management of myeloma or BEAM in lymphoma.
* A conditioning allogeneic bone marrow transplantation with reduced or intermediate busulfan IV
* Patients belong to a schema of social security, having signed the written informed consent.
Exclusion Criteria:
* patients:
* To receive or have received KGF
* With previous history of RT with the exception of patients who received spinal analgesic therapy in the treatment of myeloma
* Unable or unwilling to complete the self assessment questionnaire
* With previous history of allergy to any component of the products under consideration
* Minor
* Adults under guardianship
* Pregnant women
* Patients who have not signed the consent form
* Creation of mouthwash out of the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01426295
Study Brief:
Protocol Section:
NCT01426295